• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 459-473 of 702 results

1063 Exhibit: Fang et al JF 2015 forthcoming

Document IPR2015-01103, No. 1063 Exhibit - Fang et al JF 2015 forthcoming (P.T.A.B. Aug. 11, 2015)

cite Cite Document
Analyze

2046 Exhibit: July 2014 IRDP threatened 720 patent obviousness IPR declaration

Document IPR2015-01103, No. 2046 Exhibit - July 2014 IRDP threatened 720 patent obviousness IPR declaration (P.T.A.B. Jul. 28, 2015)

cite Cite Document
Analyze

2058 Exhibit: Talsma New Clozapine REMS program changes monitoring, dispensi...

Document IPR2015-01103, No. 2058 Exhibit - Talsma New Clozapine REMS program changes monitoring, dispensing requirements 2015 (P.T.A.B. Feb. 12, 2016)

cite Cite Document
Analyze

1052 Exhibit: FTC Statement May 2015

Document IPR2015-01103, No. 1052 Exhibit - FTC Statement May 2015 (P.T.A.B. Aug. 11, 2015)

cite Cite Document
Analyze

2051 Exhibit: Hayman Capital Management, LP Statement of J Kyle Bass Chief Inv...

Document IPR2015-01103, No. 2051 Exhibit - Hayman Capital Management, LP Statement of J Kyle Bass Chief Investment Officer, Hayman Capital Management, LP 2015 (P.T.A.B. Jul. 28, 2015)

cite Cite Document
Analyze

1003 Exhibit: Elsayed

Document IPR2015-01103, No. 1003 Exhibit - Elsayed (P.T.A.B. Apr. 23, 2015)

cite Cite Document
Analyze

1078 Exhibit: WorldCat Results for Menill

Document IPR2015-01103, No. 1078 Exhibit - WorldCat Results for Menill (P.T.A.B. Jan. 25, 2016)

cite Cite Document
Analyze

1053 Exhibit: CEPR Study Cost of Pharma IPR exemption

Document IPR2015-01103, No. 1053 Exhibit - CEPR Study Cost of Pharma IPR exemption (P.T.A.B. Aug. 11, 2015)

cite Cite Document
Analyze

2022 Exhibit: Center for Drug Evaluation and Research, FDA Transcript 47th Meeti...

Document IPR2015-01103, No. 2022 Exhibit - Center for Drug Evaluation and Research, FDA Transcript 47th Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee 1997 (P.T.A.B. Jul. 28...

cite Cite Document
Analyze

2006 Exhibit: Uhl, Kathleen, et al Thalidomide Use in the US, Experience with Pregn...

Document IPR2015-01103, No. 2006 Exhibit - Uhl, Kathleen, et al Thalidomide Use in the US, Experience with Pregnancy Testing in the STEPS Programme (P.T.A.B. Jul. 28, 2015)

cite Cite Document
Analyze

2001 Exhibit: Thalomid June 2014 Package Insert

Document IPR2015-01103, No. 2001 Exhibit - Thalomid June 2014 Package Insert (P.T.A.B. Jul. 28, 2015)

cite Cite Document
Analyze

1008 Exhibit: Cunningham

Document IPR2015-01103, No. 1008 Exhibit - Cunningham (P.T.A.B. Apr. 23, 2015)

cite Cite Document
Analyze

1005 Exhibit: Boyer

Document IPR2015-01103, No. 1005 Exhibit - Boyer (P.T.A.B. Apr. 23, 2015)

cite Cite Document
Analyze

2069 Exhibit: Declaration of John Freeman, Corporate VP, Head of Global Drug Sa...

Document IPR2015-01103, No. 2069 Exhibit - Declaration of John Freeman, Corporate VP, Head of Global Drug Safety and Risk Management, Celgene Corporation (P.T.A.B. Feb. 12, 2016)

cite Cite Document
Analyze

1074 Exhibit: IDS, Application No 12 966,240

Document IPR2015-01103, No. 1074 Exhibit - IDS, Application No 12 966,240 (P.T.A.B. Jan. 25, 2016)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 31 32 33 34 35 ... >>